New drug cocktail aims to shrink tumors before cancer surgery
NCT ID NCT07400094
Summary
This study tests a three-drug combination given before surgery for people with advanced, but operable, cancer of the mouth or voice box. Fifty participants will receive the drugs (camrelizumab, paclitaxel, and carboplatin) for three cycles, followed by surgery. The main goal is to see how well the treatment shrinks or eliminates the tumor before it is surgically removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARYNGEAL NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
P.A. Hertsen Moscow Oncology Research Institute
Moscow, Russia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.